110 related articles for article (PubMed ID: 21466358)
1. Immunohistochemical expression of neurotrophic tyrosine kinase receptors 1 and 2 in lung carcinoma: potential discriminators between squamous and nonsquamous subtypes.
Terry J; De Luca A; Leung S; Peacock G; Wang Y; Elliot WM; Huntsman D
Arch Pathol Lab Med; 2011 Apr; 135(4):433-9. PubMed ID: 21466358
[TBL] [Abstract][Full Text] [Related]
2. Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451
Tatematsu T; Sasaki H; Shimizu S; Okuda K; Shitara M; Hikosaka Y; Moriyama S; Yano M; Brown J; Fujii Y
Mol Clin Oncol; 2014 Sep; 2(5):725-730. PubMed ID: 25054037
[TBL] [Abstract][Full Text] [Related]
3. New targets bring hope in squamous cell lung cancer: neurotrophic tyrosine kinase gene fusions.
Rolfo C; Raez L
Lab Invest; 2017 Nov; 97(11):1268-1270. PubMed ID: 29085074
[TBL] [Abstract][Full Text] [Related]
4. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
Zhou Y; Sinha S; Schwartz JL; Adami GR
BMC Cancer; 2019 Jun; 19(1):607. PubMed ID: 31221127
[TBL] [Abstract][Full Text] [Related]
5. The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung.
Gao F; Griffin N; Faulkner S; Rowe CW; Williams L; Roselli S; Thorne RF; Ferdoushi A; Jobling P; Walker MM; Hondermarck H
Sci Rep; 2018 May; 8(1):8135. PubMed ID: 29802376
[TBL] [Abstract][Full Text] [Related]
6. Identifying patients with NTRK fusion cancer.
Solomon JP; Benayed R; Hechtman JF; Ladanyi M
Ann Oncol; 2019 Nov; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934
[TBL] [Abstract][Full Text] [Related]
7. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
Chen-Tsai CP; Colome-Grimmer M; Wagner RF
Dermatol Surg; 2004 Jul; 30(7):1009-16. PubMed ID: 15209791
[TBL] [Abstract][Full Text] [Related]
8. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Agackiran Y; Ozcan A; Akyurek N; Memis L; Findik G; Kaya S
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):350-5. PubMed ID: 22495379
[TBL] [Abstract][Full Text] [Related]
9. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
10. New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Bir F; Çeliker D; Evyapan BF; Yaren A; Edirne T
Turk J Med Sci; 2016 Dec; 46(6):1854-1861. PubMed ID: 28081338
[TBL] [Abstract][Full Text] [Related]
11. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
[TBL] [Abstract][Full Text] [Related]
12. Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.
Marchetti A; Felicioni L; Pelosi G; Del Grammastro M; Fumagalli C; Sciarrotta M; Malatesta S; Chella A; Barassi F; Mucilli F; Camplese P; D'Antuono T; Sacco R; Buttitta F
Hum Mutat; 2008 May; 29(5):609-16. PubMed ID: 18293376
[TBL] [Abstract][Full Text] [Related]
13.
Gambella A; Senetta R; Collemi G; Vallero SG; Monticelli M; Cofano F; Zeppa P; Garbossa D; Pellerino A; Rudà R; Soffietti R; Fagioli F; Papotti M; Cassoni P; Bertero L
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979374
[TBL] [Abstract][Full Text] [Related]
14. Targeting TRK family proteins in cancer.
Khotskaya YB; Holla VR; Farago AF; Mills Shaw KR; Meric-Bernstam F; Hong DS
Pharmacol Ther; 2017 May; 173():58-66. PubMed ID: 28174090
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of NTRK2 and NTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants.
Gimm O; Dziema H; Brown J; de la Puente A; Hoang-Vu C; Dralle H; Plass C; Eng C
Int J Cancer; 2001 Apr; 92(1):70-4. PubMed ID: 11279608
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophins and neurotrophin receptors in human lung cancer.
Ricci A; Greco S; Mariotta S; Felici L; Bronzetti E; Cavazzana A; Cardillo G; Amenta F; Bisetti A; Barbolini G
Am J Respir Cell Mol Biol; 2001 Oct; 25(4):439-46. PubMed ID: 11694449
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
18. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR
Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
[TBL] [Abstract][Full Text] [Related]
19. Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.
Shilo K; Dracheva T; Mani H; Fukuoka J; Sesterhenn IA; Chu WS; Shih JH; Jen J; Travis WD; Franks TJ
Arch Pathol Lab Med; 2007 Oct; 131(10):1555-60. PubMed ID: 17922592
[TBL] [Abstract][Full Text] [Related]
20. Identifying patients with NTRK fusion cancer.
Solomon JP; Benayed R; Hechtman JF; Ladanyi M
Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
